UK neuroscience company developing AI medical software to detect early signs of cognitive impairment, dementia and Alzheimer's disease is looking for a partner to apply to the Eureka Healthy Ageing call
The UK company based in London has developed a patented, artificial intelligence-based software that provides a five-minute test of cognitive ability, reducing time and costs associated with dementia diagnosis & care. They are looking to partner under a research cooperation agreement with an organisation with an interest in dementia detection in order to refine their ICA under the Eureka Healthy Ageing call aimed at developing digital health tools to promote healthy ageing.